Editorial: HBeAg Seroconversion Is Not Sufficient to Allow Cessation of Nucleos(t)ide Analogue Treatment in Caucasian Hepatitis B Patients
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14649
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2018
Authors
Publisher
Wiley